eClinicalMedicine Home Page
Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study - The Lancet Neurology
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study - The Lancet Rheumatology
Drug harms in the UK: a multicriteria decision analysis - The Lancet
Physicians' views of patient–planetary health co-benefit prescribing: a mixed methods systematic review - The Lancet Planetary Health
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial - The Lancet Neurology
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study - The Lancet
Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study - The Lancet Regional Health – Americas
The Lancet has made one of the biggest retractions in modern history. How could this happen? | James Heathers | The Guardian
Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance - The Lancet
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies - The Lancet Neurology
More people could benefit from antihypertensives, study finds
The Lancet Psychiatry, January 2024, Volume 11, Issue 1, Pages 1-80, e1-e3
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial - The Lancet Rheumatology
Lancet, NEJM retract Covid-19 studies that sparked backlash
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis - The Lancet
Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials - The Lancet Healthy Longevity
How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review - The Lancet Regional Health – Western Pacific
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study - The Lancet Global Health
The Lancet Haematology Home Page
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study - The Lancet
Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study - The Lancet Regional Health – Americas
Drug harms in the UK: a multicriteria decision analysis - The Lancet
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology
